Hikma Pharmaceuticals Says It Is in Talks With GlaxoSmithKline to Buy Some Businesses
January 26 2021 - 3:45AM
Dow Jones News
By Ian Walker
Hikma Pharmaceuticals PLC said Tuesday that it has entered into
a preliminary agreement with GlaxoSmithKline PLC's Egyptian
subsidiary to buy certain businesses, and expects to start due
diligence in order to proceed with talks.
The pharmaceutical group said talks relate to the potential
acquisition of Glaxo's pharmaceutical and consumer
commercialization and manufacturing business in Egypt, and
pharmaceutical business in Tunisia.
Hikma said that any deal is subject to a number of conditions,
and that there is no certainty any deal will be struck.
Hikma shares at 0810 GMT were up 1.0 pence, or 0.04%, at 2,495.0
pence.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
January 26, 2021 03:30 ET (08:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Historical Stock Chart
From Oct 2024 to Nov 2024
GSK (NYSE:GSK)
Historical Stock Chart
From Nov 2023 to Nov 2024
